Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
50.49 USD | +2.25% | -0.79% | +41.91% |
May. 10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
May. 09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRINETICS PHARMACEUTICALS, INC. | Other Biotechnology & Medical Research | +2.25% | -0.79% | +41.91% | +126.11% | +100.20% | 3.89B |
- Stock Market
- Equities
- CRNX Stock
- Charts Crinetics Pharmaceuticals, Inc.
- Relative Strength Chart